Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice

Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice

The COVID-19 pandemic continues to threaten human health worldwide as new variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerge. Currently, the predominant circulating strains around the world are Omicron variants, which can evade many therapeutic antibodies. Thus, the...

Full description

Bibliographic Details
Main Authors: Ruei-Min Lu, Kang-Hao Liang, Hsiao-Ling Chiang, Fu-Fei Hsu, Hsiu-Ting Lin, Wan-Yu Chen, Feng-Yi Ke, Monika Kumari, Yu-Chi Chou, Mi-Hua Tao, Yi-Ling Lin, Han-Chung Wu
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Heliyon
Subjects:
SARS-CoV-2
COVID-19
mRNA LNP
Antibody humanization
Neutralizing antibody
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023027949

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023027949

Similar Items